Top Markets
Coin of the day
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Kedudukan dalam Saham #6695
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jรถrgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgรฅrd Schambye, its corporate operations are based in Boston, Massachusetts.
Harga Saham
$30.90
Modal Pasaran
$1.90B
Perubahan (1 hari)
1.68%
Perubahan (1 tahun)
819.64%
Negara
US
Perdagangan Damora Therapeutics, Inc. (DMRA)

Kategori

Harga DMRA dengan permodalan pasaran b
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
DMRA
$30.90
Modal pasaran bagi Damora Therapeutics, Inc.(DMRA)
Modal Pasaran: $1.90B
Sehingga August 2026, Damora Therapeutics, Inc. mempunyai modal pasaran sebanyak $1.90B. Ini menjadikan Damora Therapeutics, Inc. syarikat ke-6695th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Damora Therapeutics, Inc. dari 2020 hingga 2026
DMRA berbanding dengan 5 teratas yang paling popular stocks
Harga DMRA Aset B Pasaran B Hasilnya
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$89,866.86 $1.90B
$5.532T +290,731.25%
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$74,864.64 $1.90B
$4.608T +242,180.40%
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$66,537.97 $1.90B
$4.096T +215,233.23%
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$60,897.21 $1.90B
$3.748T +196,978.34%
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$44,861.21 $1.90B
$2.761T +145,081.90%